275 results on '"Dong, Xuesen"'
Search Results
2. CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer
3. Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer
4. TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer
5. RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway
6. Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer
7. A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer
8. The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions.
9. A PRC2-independent function for EZH2 in regulating rRNA 2′-O methylation and IRES-dependent translation
10. Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4
11. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function
12. Characterization of a Prostate- and Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor Gene
13. LIN28B promotes the development of neuroendocrine prostate cancer
14. Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy
15. TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression
16. BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer
17. Loss of Feedback Regulation between FAM3B and Androgen Receptor Driving Prostate Cancer Progression
18. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells
19. Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancer
20. A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer
21. HoxA10 and HoxA11 Regulate the Expression of Contraction-Associated Proteins and Contribute to Regionalized Myometrium Phenotypes in Women
22. ABI1 regulates transcriptional activity of Androgen Receptor by novel DNA and AR binding mechanism
23. Abstract 3725: ABI1 regulates STAT3 transcription through a DNA binding activity
24. Abstract 1454: SMAD3 promotes expression and activity of the androgen receptor in prostate cancer
25. Figure S3 from UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling
26. Supplementary Tables from UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling
27. Supplementary Data from KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer
28. Data from UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling
29. Data from KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer
30. SMAD3 promotes expression and activity of the androgen receptor in prostate cancer
31. The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy
32. TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer
33. Freddie: annotation-independent detection and discovery of transcriptomic alternative splicing isoforms using long-read sequencing
34. Discovery of Novel Lin28 Inhibitors to Suppress Cancer Cell Stemness
35. Lin28 Regulates Cancer Cell Stemness for Tumour Progression
36. In Vivo Evidence of the Androgen Receptor in Association With Myometrial Cell Proliferation and Apoptosis
37. Interferon signalling contributes to therapy‐resistant prostate cancer progression
38. The Androgen Receptor and Its Crosstalk With the Src Kinase During Castrate-Resistant Prostate Cancer Progression
39. CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer
40. Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells
41. HoxA13 Stimulates Myometrial Cells to Secrete IL-1β and Enhance the Expression of Contraction-Associated Proteins
42. Progesterone receptor expression during prostate cancer progression suggests a role of this receptor in stromal cell differentiation
43. The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors
44. Optimization of New Catalytic Topoisomerase II Inhibitors as an Anti-Cancer Therapy
45. Transient SOX9 expression facilitates resistance to androgen-targeted therapy in prostate cancer
46. KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer
47. Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
48. Expression and Function of the Progesterone Receptor in Human Prostate Stroma Provide Novel Insights to Cell Proliferation Control
49. Proliferative Action of the Androgen Receptor in Human Uterine Myometrial Cells—A Key Regulator for Myometrium Phenotype Programming
50. Expression and Function of Myometrial PSF Suggest a Role in Progesterone Withdrawal and the Initiation of Labor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.